Epidemiology of invasive Streptococcus pneumoniae infections in children in Spain, 1996-1998

Journal of Infection

Volumn 45, Issue 3, 2002, Pages 139-143

  Diez Domingo J ^a   Pereiro I ^a   Morant, A ^a   Gimeno, C ^b   Lerma, M ^b   Oyaguez I ^c   Gonzalez A ^c   Gomez A ^d   Rabasco, M D ^d   Moreno, R ^d   Rosales, A ^d   Escoms, R ^d   Haro, J ^d   Lloret, A ^d   Garcia J M ^d   Martinez A ^d   Hernandez A ^d   Viudes, A ^d   Balaguer, M A ^d   Dominguez V ^d   De la Muela, N ^d   Llucian R ^d   Nogueira, J M ^d   Camarena, J J ^d   Snchez A ^d   Jimenez M J ^d   Igual, R ^d   Marin J ^d   Grande, D ^d   Ferreruela, R ^d   Hervas A ^d   Serrat, C ^d   Paricio, J M ^d   Martinez, C ^d   Perez, P ^d   Lopez P ^d   Herrero, A ^d   Bunuel F ^d   Alexandre, F ^d   Ortiz de la Tabla V ^d   Gonzalez R ^d   Blesa, C ^d   Tabernero, C ^d   Navarro, E ^d   Perez, T ^d   Royo, G ^d   Aceituno, M ^d   Yague A ^d   Goberna, F ^d   more..

^a Vaccine Institute of Valencia   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FATALITY; HUMAN; INCIDENCE; INFANCY; INFANT; MAJOR CLINICAL STUDY; MENINGITIS; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; SEPTICEMIA; SEROTYPE; SPAIN; STATISTICAL ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0036821532     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(02)91051-0     Document Type: Article

References (31)

1. Schuchat A, Robinson K, Wenger JD et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-976.
2. Levine MM, Lagos R, Levine OS et al. Epidemiology of invasive pneumococcal infections in infants and young children in metropolitan Santiago, Chile, a newly industrialized country. Pediatr Infect Dis J 1998; 17: 287-293.
3. MMWR. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-24.
4. Shapiro E, Berg A, Austrian R et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Eng] J Med 1991; 325: 1453-1460.
5. Butler J, Breiman R, Campbell J, Lipman H, Broome C, Facklam R. Pneumococcal polysaccharide vaccine efficacy. JAMA 1993: 270: 1826-1831.
6. Robinson KA, Baughman W, Rothrock G et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285: 1729-1735.
7. Sniadack DH, Schwartz B, Lipman H et al. Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies. Pediatr Infect Dis J 1995; 14: 503-510.
8. Von Kries R, Siedler A, Schmitt HJ, Reinert RR. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000; 31: 482-487.
9. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990; 150: 1401-1405.
10. Mufson MA, Oley G, Hughey D. Pneumococcal disease in a medium-sized community in the United States. JAMA 1982; 248: 1486-1489.
11. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS. Greenberg D, Ward JF. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174: 752-759.
12. Pastor P, Medley F, Murphy T. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis 1998; 26: 590-595.
13. Eskola J, Takala AK, Kela E, Pekkanen E, Kallioski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268: 3323-3327.
14. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981; 3: 246-253.
15. Schlech WF, Ward JL, Band WJ, Hightower A, Fraser DW, Broome CV. Bacterial meningitis in the United States, 1978 through 1981. JAMA 1985; 253: 1749-1754.
16. Hausdoff PW, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotypes frequency in young children. Lancet 2001; 357: 950-952.
17. Kapplan SL, Mason EO, Barson WJ et al. Three-year multicenter surveillance of systemic pneumococcal infection in children. Pediatrics 1998; 102: 538-545.
18. Davis CW, McIntyre PB. Invasive pneumococcal infection in children, 1981-92: A hospital-based study. J Paediatr Child Health 1995: 31: 371-372.
19. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985; 7: 133-142.
20. Denis FA, Greenwood BD, Rely JL et al. Etude multicentrique des sérotypes de pneumocoques en Afrique. Bull World Health Organ 1983; 61: 661-669.
21. Broome CV, Facklam RR, Allen JR, Fraser DW, Austrian R. Epidemiology of pneumococcal serotypes in the United States, 1978-79. J Inject Dis 1980; 141: 119-123.
22. Verhaegen J, Glupezynski, Verbist L et al. Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988. Eur J Clin Microbiol Infect Dis 1990; 9: 390-395.
23. Fenoll A, Jado I, Vicioso D, Perez A, Casal J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36: 3447-3454.
24. Hausdorff W, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100-121.
25. Appelbaum P. Antimicrobial resisitance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
26. Coffey T, Berron S, Daniels M et al. Multiply-antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiol 1996; 142: 2747-2757.
27. Kyaw MH, Clarke S, Edwards GFS, Jones IG, Campbell H. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 2000; 125: 561-572.
28. Klugman K. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
29. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997: 24: S85-S88.
30. Spoulou V, Gilks CF, Ioannidis JPA. Protein conjugate pneumococcal vaccines. Offer new opportunities for high risk individuals but still lack robust evidence. BMJ 2002: 324: 750-751.
31. Lieu TA, Ray GT, Black SB et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000; 283: 1729-1735.